🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

iDose TR Administration in an Office-Based Surgery Setting

Recruitingn/aAges 18 Years - anyAllGlaukos Corporation
NCT07816692 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of Open angle glaucoma (OAG) or ocular hypertension (OHT) Exclusion Criteria: * Prior administration of iDose TR or administration of an investigational intracameral implant in the study eye * Active ocular infection or inflammation * History of hypersensitivity to travoprost or implant components * Recent ocular surgery * Uncontrolled systemic disease * Any condition preventing safe implantation
💊

What it tests

  • iDose TR (travoprost intracameral implant) 75 µg
📍

Where

1 site
Glaukos Investigative Site
Austin, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy